New hope for kids with hard-to-treat cancers: targeted radiation plus pill
NCT ID NCT06607692
First seen Apr 17, 2026 · Last updated Apr 23, 2026 · Updated 1 time
Summary
This study is for children and teens (ages 3-18) whose solid tumors have come back or not responded to standard treatments. It combines a radioactive drug (Lutathera) that targets tumor cells with a pill (olaparib) that may make the radiation more effective. The goal is to see if this combination is safe and can shrink or control the tumors. About 25 participants will be enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
HM Monteprincipe
RECRUITINGBoadilla del Monte, Madrid, 28660, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.